Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will ...

Pfizer's (NYSE: PFE) share price has fallen more than the S&P 500 so far this year. If you're a growth investor, you probably ...

Global Leading Excipient Supplier to Highlight Innovations in Oral Disintegrating Tablets, Controlled Release Formulations, and Low-Nitrite Solutions ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

If you take one common medication for anxiety ... provider to determine whether your supply is affected): Clonazepam ODT, USP ...

The ODT market is expanding rapidly ... methylcellulose (HPMC): Enables consistent and controlled delivery of medication, enhancing therapeutic efficacy and patient compliance through customizable ...

Biohaven meanwhile recorded Nurtec ODT sales of $462 million in 2021, a performance that prompted Pfizer to stump up $500 million upfront for rights to the drug outside the US last November.

Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

such as cancer therapies Adcetris and Padcev along with migraine drug Nurtec ODT, that should help offset the revenue declines. In addition, Pfizer's pipeline looks promising with 115 programs in ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...